Status:
COMPLETED
Determination of Change in Reflux Disease After Sleeve Gastrectomy by Intraluminal Impedance and pH-meter
Lead Sponsor:
Fatih Sultan Mehmet Training and Research Hospital
Conditions:
Gastroesophageal Reflux Disease
Obesity, Morbid
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
710 / 5.000 Çeviri sonuçları Laparoscopic sleeve gastrectomy (LSG) has become the most common bariatric procedure in obesity. The overall relationship between sleeve gastrectomy and gastroesophageal r...
Detailed Description
Power analysis, Tien Yew Chern et al. (1) was based on the study conducted by As a result of the Power analysis using the G\*Power program, when the effect size d (effect size): 0.834 and SD: 38.6 wer...
Eligibility Criteria
Inclusion
- 18 years and older and younger than 65 years.
- At least 5 years of morbid obesity (BMI \>40 or \>35 and comorbidity)
- Patients with transient or inadequate response weight loss despite dieting under the guidance of a dietitian.
Exclusion
- Past upper gastrointestinal surgery,
- Paraesophageal (type 2), mixed (type 3), or sliding hiatal hernias of 3 cm or more,
- Patients with esophagitis and/or Barrett's metaplasia on upper GI endoscopy
- Those with peripheral vascular disease Those with a history of cerebrovascular accident
- Patients with coagulopathy
- History of chronic analgesic use
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05405816
Start Date
January 1 2022
End Date
September 1 2022
Last Update
February 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fatih sultan mehmet training and research hospital
Istanbul, Turkey (Türkiye), 34734